↓ Skip to main content

Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection

Overview of attention for article published in Nature Immunology, December 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
2 X users
patent
41 patents
facebook
1 Facebook page
reddit
1 Redditor
f1000
1 research highlight platform

Readers on

mendeley
398 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
Published in
Nature Immunology, December 2011
DOI 10.1038/ni.2180
Pubmed ID
Authors
Abstract

Infection of erythrocytes with Plasmodium species induces clinical malaria. Parasite-specific CD4(+) T cells correlate with lower parasite burdens and severity of human malaria and are needed to control blood-stage infection in mice. However, the characteristics of CD4(+) T cells that determine protection or parasite persistence remain unknown. Here we show that infection of humans with Plasmodium falciparum resulted in higher expression of the inhibitory receptor PD-1 associated with T cell dysfunction. In vivo blockade of the PD-1 ligand PD-L1 and the inhibitory receptor LAG-3 restored CD4(+) T cell function, amplified the number of follicular helper T cells and germinal-center B cells and plasmablasts, enhanced protective antibodies and rapidly cleared blood-stage malaria in mice. Thus, chronic malaria drives specific T cell dysfunction, and proper function can be restored by inhibitory therapies to enhance parasite control.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 398 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 6 2%
France 4 1%
United Kingdom 2 <1%
Brazil 2 <1%
Singapore 1 <1%
Sweden 1 <1%
Portugal 1 <1%
Peru 1 <1%
Korea, Republic of 1 <1%
Other 3 <1%
Unknown 376 94%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 95 24%
Researcher 83 21%
Student > Master 50 13%
Student > Bachelor 35 9%
Student > Doctoral Student 23 6%
Other 48 12%
Unknown 64 16%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 124 31%
Immunology and Microbiology 89 22%
Medicine and Dentistry 45 11%
Biochemistry, Genetics and Molecular Biology 42 11%
Pharmacology, Toxicology and Pharmaceutical Science 7 2%
Other 20 5%
Unknown 71 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2026.
All research outputs
#1,684,849
of 33,695,692 outputs
Outputs from Nature Immunology
#1,091
of 5,029 outputs
Outputs of similar age
#9,564
of 302,252 outputs
Outputs of similar age from Nature Immunology
#2
of 46 outputs
Altmetric has tracked 33,695,692 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,029 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 302,252 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.